Tag: liver cancer
Protein links liver cancer with obesity, alcoholism, and hepatitis
Obesity, alcoholism, and chronic hepatitis all increase the risk of getting liver cancer, which is the third leading cause of cancer death worldwide. Obesity...
Novel urine screening tests for liver cancer
New data from two clinical trials presented today at the International Liver Congress™ 2013 demonstrate substantial improvements in the detection of both hepatocellular carcinoma...
Fighting cancer at your local Indian restaurant
Turmeric, a bright yellow spice from south Asia belonging to the ginger family, is the main ingredient in curries -- and ancient wisdom suggests that it's also good for your health. Taking this wisdom to the laboratory, Tel Aviv University r...
A diagnostic marker in hepatocellular carcinoma
E2F5 is a member of the E2F transcription factor family, and plays a key role in cell growth and proliferation. Overexpression of E2F5 has been reported in various human cancers, but not in liver cancer, and its biological implication is largely unk...
Infiltrating cancer’s recruitment center
Tel Aviv -- The most common connective tissue cell in animals is the fibroblast, which plays an important role in healing wounds. But Dr. Neta Erez of Tel Aviv University's Sackler Faculty of Medicine has now demonstrated that fibroblasts can...
Platinum and blue light combine to combat cancer
When it comes to health care blue lights, are usually most useful on the top of ambulances but now new research led by the University of Warwick has found a way to use blue light to activate what could be a highly potent platinum-based cancer treatm...
Mayo researchers find mortality rates from liver diseases underestimated
ROCHESTER, Minn. -- Statistics from the Centers for Disease Control and Prevention (CDC) (http://www.cdc.gov/) rank mortality related to chronic liver disease and cirrhosis as the 12th most common cause of death in adults in the U.S. Using a modifie...
Blocking an oncogene in liver cancer could be potential therapy option
COLUMBUS, Ohio -- Scientists have found that a synthetic molecule they designed can block activation of a gene in liver cancer cells, halting a process that allows some of those cancer cells to survive chemotherapy.
Without the interference of t...
First clinical trials successfully completed on potent new hepatitis C drug
The first clinical trials on a new investigational drug being developed to treat infections caused by Hepatitis C virus have been successfully completed.
Completion of the initial phase (phase 1a) of trials of INX-189, discovered and first prepare...
